{"data":[{"accessionNo":"0000919574-26-006874","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-09-30","reportingPerson":"Ryan M. Lane","reportingCik":null,"personType":"IC,HC","sharesOwned":755891,"percentOfClass":4.99,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0000919574-26-006874","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-09-30","reportingPerson":"Empery Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":755891,"percentOfClass":4.99,"filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0000919574-26-004747","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Empery Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1322551,"percentOfClass":9.99,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0000919574-26-004747","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Ryan M. Lane","reportingCik":null,"personType":"HC,IN","sharesOwned":1322551,"percentOfClass":9.99,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001104659-26-086180","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Thomas A. Satterfield, Jr.","reportingCik":null,"personType":"IN","sharesOwned":975000,"percentOfClass":7.6,"filedAt":"2026-07-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"CAVU MANAGEMENT, LP","reportingCik":"0001813270","personType":"PN","sharesOwned":571305,"percentOfClass":4.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS CAPITAL MANAGEMENT, LP","reportingCik":"0001813845","personType":"PN","sharesOwned":571305,"percentOfClass":4.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"LESLIE W. KREIS","reportingCik":"0001813316","personType":"IN","sharesOwned":571305,"percentOfClass":4.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"CAVU ADVISORS, LLC","reportingCik":"0001813310","personType":"PN","sharesOwned":571305,"percentOfClass":4.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"AARON G.L. FLETCHER","reportingCik":"0001789490","personType":"IN","sharesOwned":571305,"percentOfClass":4.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS ADVISORS GP, LLC","reportingCik":"0001813844","personType":"PN","sharesOwned":571305,"percentOfClass":4.48,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS EQUITY PARTNERS II, LP","reportingCik":"0001813313","personType":"PN","sharesOwned":304684,"percentOfClass":2.39,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS EQUITY PARTNERS, LP","reportingCik":"0001813314","personType":"PN","sharesOwned":266621,"percentOfClass":2.09,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS FUND II QP, LP","reportingCik":"0001716869","personType":"PN","sharesOwned":211566,"percentOfClass":1.66,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"Bios Fund I, LP","reportingCik":"0001697316","personType":"PN","sharesOwned":151759,"percentOfClass":1.19,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS FUND I QP, LP","reportingCik":"0001700297","personType":"PN","sharesOwned":88769,"percentOfClass":0.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS FUND II, LP","reportingCik":"0001714576","personType":"PN","sharesOwned":64794,"percentOfClass":0.51,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BIOS FUND II NT, LP","reportingCik":"0001728851","personType":"PN","sharesOwned":28324,"percentOfClass":0.22,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-15","reportingPerson":"BP DIRECTORS, LP","reportingCik":"0001813311","personType":"PN","sharesOwned":26093,"percentOfClass":0.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BIOS Capital Management, LP","reportingCik":"0001813845","personType":"PN","sharesOwned":834752,"percentOfClass":7.4,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"Cavu Advisors, LLC","reportingCik":"0001813310","personType":"PN","sharesOwned":834752,"percentOfClass":7.4,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"Cavu Management, LP","reportingCik":"0001813270","personType":"PN","sharesOwned":834752,"percentOfClass":7.4,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"Kreis Leslie W.","reportingCik":"0001813316","personType":"IN","sharesOwned":834752,"percentOfClass":7.4,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"Fletcher Aaron G.L.","reportingCik":"0001789490","personType":"IN","sharesOwned":834752,"percentOfClass":7.4,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BIOS Advisors GP, LLC","reportingCik":"0001813844","personType":"PN","sharesOwned":834752,"percentOfClass":7.4,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"Bios Equity Partners, LP","reportingCik":"0001813314","personType":"PN","sharesOwned":420802,"percentOfClass":3.7,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"Bios Equity Partners II, LP","reportingCik":"0001813313","personType":"PN","sharesOwned":413950,"percentOfClass":3.7,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BIOS Fund II QP, LP","reportingCik":"0001716869","personType":"PN","sharesOwned":287442,"percentOfClass":2.6,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BIOS Fund I, LP","reportingCik":"0001697316","personType":"PN","sharesOwned":249037,"percentOfClass":2.2,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BIOS Fund I QP, LP","reportingCik":"0001700297","personType":"PN","sharesOwned":145672,"percentOfClass":1.3,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BIOS Fund II, LP","reportingCik":"0001714576","personType":"PN","sharesOwned":88029,"percentOfClass":0.8,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BIOS Fund II NT, LP","reportingCik":"0001728851","personType":"PN","sharesOwned":38479,"percentOfClass":0.3,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000005","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-16","reportingPerson":"BP Directors, LP","reportingCik":"0001813311","personType":"PN","sharesOwned":26093,"percentOfClass":0.2,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001104659-26-039486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":"51654W101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-30","reportingPerson":"Thomas A. Satterfield, Jr.","reportingCik":null,"personType":"IN","sharesOwned":570000,"percentOfClass":5.1,"filedAt":"2026-04-03","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"AARON G.L. FLETCHER","reportingCik":"0001789490","personType":"IN,OO","sharesOwned":960026,"percentOfClass":8.58,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS CAPITAL MANAGEMENT, LP","reportingCik":"0001813845","personType":"PN","sharesOwned":960026,"percentOfClass":8.58,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS ADVISORS GP, LLC","reportingCik":"0001813844","personType":"PN","sharesOwned":960026,"percentOfClass":8.58,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"CAVU MANAGEMENT, LP","reportingCik":"0001813270","personType":"PN","sharesOwned":960026,"percentOfClass":8.58,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"CAVU ADVISORS, LLC","reportingCik":"0001813310","personType":"PN","sharesOwned":960026,"percentOfClass":8.58,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"LESLIE W. KREIS","reportingCik":"0001813316","personType":"IN","sharesOwned":960026,"percentOfClass":8.58,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS EQUITY PARTNERS, LP","reportingCik":"0001813314","personType":"PN","sharesOwned":481947,"percentOfClass":4.31,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS EQUITY PARTNERS II, LP","reportingCik":"0001813313","personType":"PN","sharesOwned":478079,"percentOfClass":4.27,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS FUND II QP, LP","reportingCik":"0001716869","personType":"PN","sharesOwned":331974,"percentOfClass":2.97,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"Bios Fund I, LP","reportingCik":"0001697316","personType":"PN","sharesOwned":287619,"percentOfClass":2.57,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS FUND I QP, LP","reportingCik":"0001700297","personType":"PN","sharesOwned":168235,"percentOfClass":1.5,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS FUND II, LP","reportingCik":"0001714576","personType":"PN","sharesOwned":101665,"percentOfClass":0.91,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BIOS FUND II NT, LP","reportingCik":"0001728851","personType":"PN","sharesOwned":44440,"percentOfClass":0.4,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"},{"accessionNo":"0001813314-26-000002","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001763950","issuerName":"Lantern Pharma Inc.","ticker":"LTRN","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-20","reportingPerson":"BP DIRECTORS, LP","reportingCik":"0001813311","personType":"PN","sharesOwned":26093,"percentOfClass":0.23,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn"}],"updatedAt":"2026-11-03T14:47:47.976Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ltrn","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}